Most Recent
Airbags class action judge failed to grapple with ‘unknowable’ explosion risk, appeals court hears
The plaintiff in a class action against Volkswagen over allegedly deadly Takata airbags has told an appeals court his case was misunderstood by the trial judge, who found he failed to prove that cars fitted with the airbags were not of acceptable quality.
7-Eleven class action funder’s commission should be cut by $10M, court told
Litigation funder Galactic should receive a $15 million commission for its work on two franchisee class actions against convenience store giant 7-Eleven, instead of the $25 million it has asked for, a court has heard.
JD Group wins stay of damages for couple ‘misled’ over $10M luxury digs
Damages owed to a millionaire couple by JD Group over a "deliberately misleading" rendering of a $9.58 million apartment in South Yarra, Melbourne will be put on ice pending the outcome of the property developer's appeal.
Peters served with $12M penalty for exclusive dealing
Peters Ice Cream has been hit with a $12 million penalty after admitting to entering an anti-competitive exclusive agreement for distribution of its single serve ice creams to service stations and convenience stores across Australia.
Epic Games resists bid to delay Apple trial while Google catches up
Epic Games has argued in favour of steaming ahead with a trial in its competition case against Apple while its parallel case against Google remains in the embryonic stage, but the tech giants say Google's litigation should catch up in the hopes that the court can hear a joint trial or hold contemporaneous hearings.
Judge questions if Philips class action ‘appropriately resourced’
A judge has questioned whether the lead applicant in a class action over sleep apnea machines with alleged safety defects was “appropriately resourced” to run the case against health tech giant Philips.
ACCC says agreement to settle Revlimid patent suit could violate cartel laws
The ACCC has refused to authorise a patent settlement and license agreement between Bristol-Myers Squibb unit Celgene and two generic drug makers who sued to invalidate the patents for its blockbuster cancer drug Revlimid, saying it could distort competition between generic drug makers.
Corestaff group members would get less than half of $6.4M settlement if funder seeks 35% cut
Group members in a class action by Papua New Guinea workers against labour hire firm CoreStaff would get less than half of a $6.4 million settlement if the funder that backed the case seeks a common funder order for a 35 per cent commission.
Court appoints contradictor in class action funder’s challenge to MIS rules
The Full Federal Court has appointed a contradictor to "take up the cudgels" against funder Litigation Capital Management, which has challenged a judgment refusing to find that a class action filed against Queensland electricity operators was not a managed investment scheme.
Developer misled buyers of $9.58M South Yarra apartment with ‘artistic impression’
Property developer JD Group will have to pay damages to a Melbourne couple after a judge found the company’s artistic renderings of a $9.58 million South Yarra apartment were “deliberately misleading”.